HPLC-fluorescence assay for measuring mosapride in small volumes of rat plasma

被引:3
作者
Cheng, Ching-Ling [2 ]
Chang, Ya-Win [1 ]
Chou, Chen-Hsi [1 ,3 ,4 ]
机构
[1] Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm, Tainan 70101, Taiwan
[2] Chia Nan Univ Pharm & Sci, Dept Pharm, Jen Te Shiang 71710, Tainan County, Taiwan
[3] Natl Cheng Kung Univ, Coll Med, Inst Biopharmaceut Sci, Tainan 70101, Taiwan
[4] Natl Cheng Kung Univ Hosp, Dept Pharm, Tainan 70403, Taiwan
关键词
mosapride; gastroprokinetic agent; HPLC-fluorescence; pharmacokinetics; rat; PERFORMANCE LIQUID-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; BULK DRUG SAMPLES; GASTROPROKINETIC AGENT; ORAL ADMINISTRATIONS; CITRATE; VALIDATION; PHARMACOKINETICS; QUANTITATION;
D O I
10.1002/bmc.1285
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple and sensitive HPLC-fluorescence assay was developed for the determination of a gastroprokinetic agent mosapride in small volumes of rat plasma. Samples (50 mu L) were treated with 200 mu L of the internal standard solution (cisapride, 0.1 mu g/mL in acetonitrile). Chromatographic separation was achieved on a C-18 column by gradient elution with the mobile phase of acetonitrile-water containing 20 mm potassium dihydrogen phosphate,at a flow rate of 1 mL/min. Fluorescence was measured with excitation and emission set at 315 and 354 nm, respectively. The retention time was about 16 min for cisapride and 20 min for mosapride. No endogenous substances were found to interfere. The calibration curve was linear from 0.015 to 10 mu g/mL. The lower limit of quantification was 0.015 mu g/mL. The intra- and inter-day precision expressed as relative standard deviation did not exceed 7.7%, and the accuracy was within 4.7% deviation of the nominal concentration. The method was used successfully to investigate the disposition kinetics of mosapride in rats. Copyright (C) 2009 John Wiley & Sons, Ltd.
引用
收藏
页码:281 / 288
页数:8
相关论文
共 22 条
[1]   Liquid chromatography-tandem mass spectrometric method for determination of mosapride citrate in equine tissues [J].
Aoki, Yoichi ;
Hakamata, Hideki ;
Igarashi, Yu ;
Uchida, Kazunari ;
Kobayashi, Hisato ;
Hirayama, Norio ;
Kotani, Akira ;
Kusu, Fumiyo .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 858 (1-2) :135-142
[2]   Mosapride improves food intake, while not worsening glycemic control and obesity, in ob/ob obese mice with decreased gastric emptying [J].
Asakawa, A ;
Ueno, N ;
Katagi, M ;
Ijuin, Y ;
Morita, Y ;
Mizuno, S ;
Inui, T ;
Sakamaki, R ;
Shinfuku, N ;
Uemoto, M .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2006, 20 (01) :56-58
[3]   Development and validation of a high-performance liquid chromatographic method using fluorescence detection for the determination of vardenafil in small volumes of rat plasma and bile [J].
Cheng, Ching-Ling ;
Kang, Guei-Jen ;
Chou, Chen-Hsi .
JOURNAL OF CHROMATOGRAPHY A, 2007, 1154 (1-2) :222-229
[4]   Determination of tadalafil in small volumes of plasma by high-performance liquid chromatography with UV detection [J].
Cheng, CL ;
Chou, CH .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 822 (1-2) :278-284
[5]   Determination of lamotrigine in small volumes of plasma by high-performance liquid chromatography [J].
Cheng, CL ;
Chou, CH ;
Hu, OYP .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 817 (02) :199-206
[6]   Rapid and sensitive quantitation of the antiproliferative agent mitoguazone in small volumes of plasma by high-performance liquid chromatography with ultraviolet detection [J].
Cheng, CL ;
Lin, EG ;
Chou, CH .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 793 (02) :281-289
[7]   Determination of delavirdine in very small volumes of plasma by high-performance liquid chromatography with fluorescence detection [J].
Cheng, CL ;
Chou, CH ;
Hu, OYP .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 769 (02) :297-303
[8]   Mosapride - In gastrointestinal disorders [J].
Curran, Monique P. ;
Robinson, Dean M. .
DRUGS, 2008, 68 (07) :981-991
[9]   Drug interaction between mosapride and erythromycin without electrocardiographic changes [J].
Katoh, T ;
Saitoh, H ;
Ohno, N ;
Tateno, M ;
Nakamura, T ;
Dendo, I ;
Kobayashi, S ;
Nagasawa, K .
JAPANESE HEART JOURNAL, 2003, 44 (02) :225-234
[10]  
Kojima Yu, 2006, Journal of Smooth Muscle Research, V42, P139, DOI 10.1540/jsmr.42.139